Til patienter i hæmodialyse og patienter med svært nedsat nyrefunktion (GFR < 30 ml/ min.) bør dosis reduceres med 50%.
For patients that require haemodialysis and in patients with severe renal impairment (GFR < 30 ml/ min), the dose should be reduced by 50%.